Production (Stage)
E
Universal Ibogaine Inc. IBO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Net Income 7.42% -88.71% -23.51% 15.38% 75.03%
Total Depreciation and Amortization 0.73% 4.30% 7.48% 14.55% 14.48%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 32.84% 431.92% 158.42% 115.90% -84.22%
Change in Net Operating Assets -361.14% -176.59% -172.01% -145.34% 84.23%
Cash from Operations 16.27% -143.79% -7.59% 24.49% 74.40%
Capital Expenditure 73.08% 60.14% 83.82% 78.47% 78.78%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 73.08% 60.14% 83.82% 78.47% -125.98%
Total Debt Issued -- -- -- -- -100.00%
Total Debt Repaid -65.66% -111.71% -148.02% -213.35% 20.16%
Issuance of Common Stock -84.40% 190.70% 1,430.00% 202.13% 161.35%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 194.78% -240.63% -- -- --
Cash from Financing -67.56% 39.51% 49.57% -7.59% -1.56%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -390.08% -155.40% 88.22% 114.32% 107.04%